CENTOGENE News & Events Header Image Broschure

News

Stay up to date and read about our most recent milestones towards achieving CENTOGENE’s mission: To enable the cure of 100 rare diseases in 10 years.

Interested in receiving the latest news around the clock? Follow us on LinkedIn.

CENTOGENE Smartphone App myLSDapp Now Available in Spanish

Gaucher Disease Monitoring and Treatment Management

Cambridge, MA USA & Rostock, Germany, March 24, 2020 – CENTOGENE (Nasdaq: CNTG) today announced…

Read more

CENTOGENE Announces Changes in Supervisory Board

Cambridge, MA, USA and Rostock/Berlin, Germany, March 17, 2020 (Globe Newswire) – CENTOGENE N.V. (Nasdaq: CNTG), a commercial-stage company focused on…

Read more

CENTOGENE Announces Departure of Dirk Ehlers From Executive Board

Cambridge, MA, USA and Rostock/Berlin, Germany, March 9, 2020 – CENTOGENE (Nasdaq: CNTG) ─ The Company today announced that Dr. Dirk H. Ehlers, COO…

Read more

CENTOGENE, OMER, and ALIBER’s Rare Disease Day Event in Mexico City 2020: Inspiring Insights on Patient Organizations’ Contributions to Solutions for Patients in Latin America

Mexico City, February 29, 2020- More than 300 participants gathered on Saturday at Hotel Marriot Reforma in Mexico City to raise awareness about rare…

Read more

CENTOGENE Marks Rare Disease Day 2020 With a Global Line up of Events

Cambridge, MA, USA & Rostock/Berlin, Germany, February 29, 2020 – CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that…

Read more

Rare Disease Associations Fight for Better Patient Health Care

On Saturday, February 29th, CENTOGENE, OMER, and ALIBER will celebrate International Rare Disease Day with an event for patients, healthcare…

Read more

CENTOGENE Expands Senior Leadership Team with Newly Appointed Chief Data Officer

Cambridge, MA, USA & Rostock, Germany – February 25, 2020 – CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that…

Read more

CENTOGENE Biobank Receives Accreditation from College of American Pathologists

State-of-the-art Biorepository in Rostock, Germany is the first CAP-accredited repository outside the U.S.

Cambridge, MA, USA & Rostock, Germany…

Read more

CentoMD® Update Reveals Continued Growth of Rare Hereditary Disease Knowledge Base

Supporting Patients for Accelerated Diagnosis and Treatment Development

Cambridge, MA USA & Rostock, Germany December 13, 2019 - In an update…

Read more

CENTOGENE Expands Executive Leadership Team

Cambridge, MA USA & Rostock, Germany December 6, 2019 – CENTOGENE (Nasdaq: CNTG) today announced the expansion of its executive leadership team with…

Read more

For Further Inquiries Please Contact

Press Contact

Melissa Hall

Corporate Communications

Email Us

Downloads

Here you can find forms, brochures, flyer and information sheets for download (PDF) about the broad genetic testing product and service portfolio of CENTOGENE.

Downloads